1, Shanghai Pharmaceutical (Group) Co., Ltd.
2. China Pharmaceutical Group Company.
3. Guangzhou Pharmaceutical Group Co., Ltd.
4. Tianjin Pharmaceutical Group Co., Ltd.
5. Shandong Dong 'e Ejiao Group Co., Ltd.
6. Harbin Pharmaceutical Group Co., Ltd
7. Nanjing Pharmaceutical Industry (Group) Co., Ltd.
8. North China Pharmaceutical Group Co., Ltd.
9. Jiangsu Yang Zijiang Pharmaceutical Group Company.
10, Taiji Group Co., Ltd. ..
20 17 ten changes of pharmaceutical enterprises in China.
The consistency evaluation of 1. will lead to a decreasing trend in the number of approvals of chemical pharmaceutical production enterprises, and the phenomenon that an enterprise only keeps the approvals of main products within 10 will widely appear.
2. The verification of the production process of traditional Chinese medicine makes the production cost of Chinese patent medicine rise sharply. Many factors contributed to the increase of drugs by more than 20% or even higher in 20 17 years, and small and medium-sized pharmaceutical companies without strength gradually went out.
3. The GMP certificate of Chinese herbal pieces production enterprises has been revoked or revoked. Traditional Chinese medicine formula granules will become the "crown jewel" in Chinese medicine pieces, and brand traditional Chinese medicine formula granules enterprises begin to appear.
4.20 17 Medical institutions generally implement clinical pathway management, and hospital products that are not included in the catalogue of clinical pathway use guidelines will gradually withdraw from the hospital market.
5. The era of prescription drugs with gold is fading away, the era of academic promotion has arrived, and the era of sales promotion has arrived.
6. In order to better cope with the two-vote system, pharmaceutical companies have set up consulting companies to deal with it.
7. Foreign pharmaceutical companies outsource expired drugs to China pharmaceutical companies, and domestic small and medium-sized pharmaceutical companies try CSO.
8. With the expansion of the primary health care market, more and more pharmaceutical companies try green therapy to enter the primary market.
9. More and more large prescription drug companies are transforming into OTC market. 1 A pharmaceutical company applied for OTC status for a product, and the phenomenon that many companies benefited began to appear.
10, more and more pharmaceutical companies enter the off-campus market, and off-campus sales will become the main battlefield for pharmaceutical companies in the future.